Predictors of Opioid-Induced Respiratory Depression (OIRD)

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

April 30, 2015

Primary Completion Date

April 29, 2018

Study Completion Date

April 29, 2018

Conditions
Respiratory Depression
Interventions
DRUG

Remifentanil

The opioid used for this study is Remifentanil and is commonly used in the operating room. Remifentanil will be given under normoxic (breathing room air \[21% Oxygen\]) and hyperoxic (breathing 50% oxygen) conditions to determine if the measurement of the specific respiratory parameters will predict the OIRD response.

DRUG

Oxygen

Remifentanil will be administered under normal oxygen (normoxia) and increased oxygen (hyperemic) conditions.

DRUG

Carbon dioxide

Carbon dioxide is used as part of the hypercapnia ventilatory response measurement (HCVR)

Trial Locations (1)

27710

Duke University Health Systems, Durham

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Duke University

OTHER